4.08
Cytomx Therapeutics Inc Borsa (CTMX) Ultime notizie
MSN Money - MSN
CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Certain Restricted Stock Units of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2026. - marketscreener.com
170,186,365 Common Stock of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2026. - marketscreener.com
CytomX (NASDAQ: CTMX) proxy adds share capacity and expands equity plans - Stock Titan
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 - Yahoo Finance UK
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright & Co. Upgrades CytomX Therapeutics (CTMX) - MSN
CytomX stock rises 31% in a month: Here's what you should know - MSN
Cantor Fitzgerald Initiates Coverage of CytomX Therapeutics (CTMX) with Overweight Recommendation - MSN
CytomX Therapeutics launches $250M public offering - MSN
Wall Street Zen Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Strong Sell - MarketBeat
CytomX Therapeutics (NASDAQ:CTMX) Stock Price Crosses Below 50-Day Moving AverageHere's What Happened - MarketBeat
CytomX Therapeutics prices $250M public offering at $5.30 per share - MSN
CTMX Stock Price, Quote & Chart | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill
CTMX (CytomX Therapeutics Inc.) shares climb over 7 percent despite wider than expected Q4 2025 per share losses.Margin of Safety - Cổng thông tin điện tử tỉnh Tây Ninh
Small Cap or Megacap: Which Healthcare Stock Is Right for You? - The Motley Fool
CTMX Forecast, Price Target & Analyst Ratings | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill
Analysts bullish on CytomX Therapeutics (CTMX) as CTMX prices $250 million offering - MSN
CytomX (NASDAQ: CTMX) seeks shareholder OK to double authorized shares to 600M - Stock Titan
CytomX Therapeutics (CTMX) gains analyst confidence on trial progress - MSN
HC Wainwright & Co. Maintains CytomX Therapeutics (CTMX) Buy Recommendation - MSN
CytomX Therapeutics (CTMX) making progress on key metastatic colorectal cancer treatment - MSN
CytomX Therapeutics Inc Share PriceCTMX, RNS News, Articles, Quotes, & Charts (NASDAQ:CTMX) - Proactive financial news
CTMX SEC FilingsCytomx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why CTMX Stock Is Soaring 54% Pre-Market Today? - MSN
Point72 (CTMX) reports 10,864,581 shares, a 5.0% holding in CytomX - Stock Titan
Traders Buy High Volume of CytomX Therapeutics Put Options (NASDAQ:CTMX) - MarketBeat
CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 6.3%Time to Buy? - MarketBeat
CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a 199.71% Potential Upside in the Biotech Innovator - DirectorsTalk Interviews
CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress - Insider Monkey
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):